EFFICACY OF AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN PATIENTS. LITERATURE REVIEW
Introduction: Cardiovascular disease is the leading cause of death worldwide. Technological advances such as the implantable cardioverter defibrillator (ICD) also play a key role in the treatment of cardiovascular disease. An ICD can correct an abnormal heart rhythm. The aim is to study the effectiveness of ICD in heart disease. Methods: Literature search was carried out in databases: PubMed, the Cochrane Library. The search strategy included the following keywords: implantable cardioverter defibrillator, efficiency, or effectiveness, quality of life, sudden cardiac death. Methodological filters included systematic reviews and meta-analyzes. The search was limited to English and Russian, published between January 2011 and April 2021. Inclusion criterion: 1) full texts available in databases; 2) texts in English or Russian; 3) research carried out or published over the past decade (2011-2021); 4) systematic reviews and meta-analyzes. Quality of the included studies was analyzed using the AMSTAR 2 checklist. Results: The studies included the effectiveness of ICD for the prevention of sudden cardiac death, left ventricular dysfunction without coronary artery disease and with ischemic heart disease, with cardiac resynchronization therapy, clinical outcomes and complications in patients with hypertrophic cardiomyopathy and ventricular arrhythmia. Conclusions: Currently available data demonstrate that the use of ICD is an important treatment option in comparison with the alternative therapies.
Temirkhan Begisbayev1, https://orcid.org/0000-0001-7536-3947 Valikhan Akhmetov1, https://orcid.org/0000-0003-4462-4504 Dmitry Hvan2, https://orcid.org/0000-0002-5925-2275 Nurken Abdiev1, https://orcid.org/0000-0002-8806-8119 Shattyk Toleugali3, https://orcid.org/0000-0001-6496-6849 1 Kazakhstan`s Medical University " Graduate School of Public Health", Almaty, Republic of Kazakhstan; 2 National Medical Research Center named after Academician E. Meshalkin, Ministry of Health of the Russian Federation, Novosibirsk, Russian Federation; 3 Asfendiyarov Kazakh National medical university, Almaty, Republic of Kazakhstan.
1. Бокерия Л.А. и др. Имплантируемые кардиовертеры-дефибрилляторы в профилактике внезапной сердечной смерти // Терапевтический архив 12, 2017. https://doi.org/10.17116/terarkh20178912; 103-109. 2. Бокерия Л.А., Ревишвили А.Ш., Неминущий Н.М. Внезапная сердечная смерть. М.: ГЭОТАР-Медиа, 2013. — 272 p. 3. Мареев В. Ю., Фомин И. В., Агеев Ф. Т. и др. Клинические рекомендации ОССН-РКО-РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение. // Кардиология. 2018. 58(6S):8-158. doi:10.18087/cardio.2475. 4. Постол А. С., Неминущий Н. М., Иванченко А. В. и др. Альтернативный метод программирования кардиоресинхронизирующих устройств для эффективной терапии // Анналы аритмологии. 2018;15(3):185-90. doi:10.15275/annaritmol.2018.3.7. 5. Ревишвили А.Ш. Всероссийское научное общество специалистов по клинической электрофизиологии, аритмологии и кардиостимуляции (ВНОА). Клинические рекомендации по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств. 2017. 470-478 с. 6. AlTurki A., Proietti R., Alturki H., Essebag V., Huynh T. Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis // Hellenic J Cardiol. 2019. Sep-Oct. 60 (5):276-281. doi: 10.1016/j.hjc.2017.12.003. Epub 2017 Dec 29. PMID: 29292244. https://pubmed.ncbi.nlm.nih.gov/29292244/ 7. Arend F.L. Schinkel A.F., Vriesendorp P.A., Sijbrands E.J.,et al. Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis // Circ Heart Fail. 2012 Sep 15(5):552-9. doi: 10.1161/circheartfailure.112.969626. Epb 2012 Jul 20. PMID: 22821634. https://pubmed.ncbi.nlm.nih.gov/22821634 8. Barakat A.F., Saad M., Elgendy A.Y., et al. Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials // BMJ Open. 2017. 7(6):e016352. Published 2017 Jun 21. doi:10.1136/bmjopen-2017-016352 9. Barra S., Providência R., Tang A., Heck P., Virdee M., Agarwal S. Importance of Implantable Cardioverter-Defibrillator Back-Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta-Analysis // J Am Heart Assoc. 2015 Nov 6. 4(11):e002539. doi: 10.1161/JAHA.115.002539. PMID: 26546574; PMCID: PMC4845241. 10. Barakat A.F., Saad M., Elgendy A.Y., et al. Chen T.H., Wo H.T., Chang P.C., Wang C.C., Wen M.S., Chou C.C. A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs) // PLoS One. 2014. 9(7):e99418. Published 2014 Jul 18. doi:10.1371/journal.pone.0099418 11. Chen TH, Wo HT, Chang PC, Wang CC, Wen MS, Chou CC. A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs). PLoS One. 2014;9(7):e99418. Published 2014 Jul 18. doi:10.1371/journal.pone.0099418 12. Chia Pow-Li, David Foo. Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management // Singapore medical journal vol. 57,7 (2016): 354-9. doi:10.11622/smedj.2016117 13. Claro J.C., Candia R., Rada G., Baraona F., Larrondo F, Letelier L.M. Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death // Cochrane Database Syst Rev. 2015. 2015(12):CD008093. Published 2015 Dec 8. doi:10.1002/14651858.CD008093.pub2 14. Peck KY, Lim YZ, Hopper I, Krum H. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients. Int J Cardiol. 2014 May 1;173(2):197-203. doi: 10.1016/j.ijcard.2014.02.014. Epub 2014 Feb 22. PMID: 24636548. 15. Katritsis D.G., Siontis K.C., Bigger J.T., Kadish A.H., Steinman R., Zareba W., Siontis G.C., Bardy G.H., Ioannidis J.P. Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials // Heart Rhythm. 2013 Feb. 10(2):200-6. doi: 10.1016/j.hrthm.2012.10.039. Epub 2012 Oct 27. PMID: 23107652. 16. Kawakami H., Nerlekar N., Haugaa K.H., Edvardsen T., Marwick T.H. Prediction of Ventricular Arrhythmias With Left Ventricular Mechanical Dispersion: A Systematic Review and Meta-Analysis // JACC Cardiovasc Imaging. 2020 Feb. 13(2 Pt 2):562-572. doi: 10.1016/j.jcmg.2019.03.025. Epub 2019 Jun 12. PMID: 31202762. 17. Masri Ahmad et al. “Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Systematic Review and Meta-Analysis” // JACC. Clinical electrophysiology vol. 5,2 (2019): 152-161. doi:10.1016/j.jacep.2018.11.011 18. Miller J.D., Yousuf O., Berger R.D. The implantable cardioverter-defibrillator: An update //. Trends Cardiovasc Med. 2015 Oct. 25(7):606-11. doi: 10.1016/j.tcm.2015.01.015. Epub 2015 Feb 7. PMID: 25912255 19. Mirowski M., Reid P.R., Mower M.M., et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980. 303(6):322-324.https://doi.org/10.1016/s0196-0644(80)80503-8 20. Moss A.J., Zareba W., Hall W.J., et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction // N Engl J Med в. 2002 346(12):877-883 https://doi.org/10.1056/nejmoa013474 21. Barakat A.F., Saad M., Elgendy A.Y., et al. Exercise-based cardiac rehabilitation for adult pa14Ъtients with an implantable cardioverter defibrillator // Cochrane Database Syst Rev. 2019;2(2):CD011828. Published 2019 Feb 12. doi:10.1002/14651858.CD011828.pub2 22. Pun P.H., Al-Khatib S.M., Han J.Y., Edwards R., Bardy G.H., Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials // Am J Kidney Dis. 2014 Jul. 64(1):32-9. doi: 10.1053/j.ajkd.2013.12.009. Epub 2014 Feb 8. PMID: 24518128; PMCID: PMC4383404. https://pubmed.ncbi.nlm.nih.gov/24518128/ 23. Patrick H. Pun, Sana M. Al-Khatib, Joo Yoon Han, Rex Edwards, et al. Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death in CKD: A Meta-analysis of Patient-Level Data from 3 Randomized Trials // Am J Kidney Dis. 2014 July. 64(1): 32–39. doi:10.1053/j.ajkd.2013.12.009. 24. Romero J. et al. Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials. Europace. 2018 Sep 1;20(FI2):f211-f216. doi: 10.1093/europace/eux324. PMID: 29161424. 25. Shun-Shin M.J., Zheng S.L., Cole G.D., Howard J.P., et al. Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials // Eur Heart J. 2017;38(22):1738-1746. doi:10.1093/eurheartj/ehx028 26. Solomon S.D., Wang D., Finn P. et al. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2004;110:2180–3 27. Stavrakis S., Asad Z., Reynolds D. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials // J Cardiovasc Electrophysiol. 2017 Jun;28(6):659-665. doi: 10.1111/jce.13204. Epub 2017 Apr 18. PMID: 28316104. 28. Wellens H.J., Schwartz P.J., Lindemans F.W., Buxton A.E., et al. Risk stratification for sudden cardiac death: current status and challenges for the future // Eur Heart J 2014; 35:1642-1651. https://doi.org/10.1093/eurheartj/ehu176 29. Vehmeijer J.T., Brouwer T.F., Limpens J., et al. Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis // Eur Heart J. 2016;37(18):1439-1448. doi:10.1093/eurheartj/ehv735 References [1-5]: 1. Bokeriya L.A. i dr. Implantiruemye kardiovertery-defibrillyatory v profilaktike vnezapnoi serdechnoi smerti. [Implantable cardioverters-defibrillators in the prevention of sudden cardiac death.] Terapevticheskii arkhiv [Therapeutic archive]. 2017. 12, 103-109 https://doi.org/10.17116/terarkh20178912; [In Russian] 2. Bokeriya L.A., Revishvili A.Sh., Neminushchii N.M. Vnezapnaya serdechnaya smert'. [Sudden cardiac death]. M.: GEOTAR-Media, 2013. 272 p. [In Russian] 3. Mareev V.Yu., Fomin I.V., Ageev F.T. i dr. Klinicheskie rekomendatsii OSSN-RKO-RNMOT. Serdechnaya nedostatochnost': khronicheskaya (KhSN) i ostraya dekompensirovannaya (ODSN). Diagnostika, profilaktika i lechenie. [Heart failure: chronic (CHF) and acute decompensated (CHF). Diagnosis, prevention and treatment]. Kardiologiya [Cardiology.] 2018. 58(6S):8-158. doi:10.18087/cardio.2475. [In Russian] 4. Postol A. S., Neminushchii N. M., Ivanchenko A. V. i dr. Al'ternativnyi metod programmirovaniya kardioresinkhroniziruyushchikh ustroistv dlya effektivnoi terapii. [An alternative method of programming cardioresynchronizing devices for effective therapy]. Annaly aritmologii [Annals of arrhythmology]. 2018;15(3):185-90. doi:10.15275/annaritmol.2018.3.7. [In Russian] 5. Revishvili A.Sh. Vserossiiskoe nauchnoe obshchestvo spetsialistov po klinicheskoi elektrofiziologii, aritmologii i kardiostimulyatsii (VNOA). Klinicheskie rekomendatsii po provedeniyu elektrofiziologicheskikh issledovanii, kateternoi ablyatsii i primeneniyu implantiruemykh antiaritmicheskikh ustroistv. [All-Russian Scientific Society of Specialists in Clinical Electrophysiology, Arrhythmology and Pacing (VNOA). Clinical recommendations for conducting electrophysiological studies, catheter ablation and the use of implantable antiarrhythmic devices]. 2017. 470-478 p. [In Russian]
Number of Views: 125

Key words:

Bibliography link

Begisbayev T., Akhmetov V., Hvan D., Abdiev N., Toleugali Sh. Efficacy of an implantable cardioverter-defibrillator in patients. Literature review // Nauka i Zdravookhranenie [Science & Healthcare]. 2021, (Vol.23) 5, pp. 203-212. doi 10.34689/SH.2021.23.5.022

Авторизируйтесь для отправки комментариев